Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Multi-indication and Combination Pricing and Reimbursement of Pharmaceuticals: Opportunities for Improved Health Care through Faster Uptake of New Innovations.

Persson U, Norlin JM.

Appl Health Econ Health Policy. 2018 Apr;16(2):157-165. doi: 10.1007/s40258-018-0377-7.

PMID:
29470774
2.

Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model.

Thomsen LH, Fog-Tonnesen M, Nielsen Fink L, Norlin J, García de Vinuesa A, Hansen TK, de Heer E, Ten Dijke P, Rosendahl A.

Ren Fail. 2017 Nov;39(1):629-642. doi: 10.1080/0886022X.2017.1361837.

PMID:
28805484
3.

Patient-reported outcomes in topical field treatment of actinic keratosis in Swedish and Danish patients.

Norrlid H, Norlin JM, Holmstrup H, Malmberg I, Sartorius K, Thormann H, Jemec GBE, Ragnarson Tennvall G.

J Dermatolog Treat. 2018 Feb;29(1):68-73. doi: 10.1080/09546634.2017.1329514. Epub 2017 Jun 29.

PMID:
28658998
4.

Effects of insulin and the glucagon-like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db mice.

Liljedahl L, Norlin J, McGuire JN, James P.

Physiol Rep. 2017 Mar;5(6). pii: e13187. doi: 10.14814/phy2.13187.

5.

Real-world outcomes in 2646 psoriasis patients: one in five has PASI ≥10 and/or DLQI ≥10 under ongoing systemic therapy.

Norlin JM, Calara PS, Persson U, Schmitt-Egenolf M.

J Dermatolog Treat. 2017 Sep;28(6):500-504. doi: 10.1080/09546634.2017.1289147. Epub 2017 Mar 2.

PMID:
28132580
6.

Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members.

Høj Thomsen L, Fog-Tonnesen M, Nielsen Fink L, Norlin J, de Vinuesa AG, Krarup Hansen T, de Heer E, Ten Dijke P, Rosendahl A.

Nephron. 2017;135(4):291-306. doi: 10.1159/000453337. Epub 2017 Jan 7.

PMID:
28064277
7.

Patient-reported adherence and persistence to topical treatments for actinic keratosis: a longitudinal diary study.

Erntoft S, Norlin JM, Pollard C, Diepgen TL.

Br J Dermatol. 2016 Nov;175(5):1094-1096. doi: 10.1111/bjd.14680. Epub 2016 Sep 19. No abstract available.

PMID:
27088541
8.

N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models.

Liljedahl L, Pedersen MH, Norlin J, McGuire JN, James P.

Clin Proteomics. 2016 Oct 15;13:22. eCollection 2016.

9.

Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy.

Norlin J, Nielsen Fink L, Helding Kvist P, Douglas Galsgaard E, Coppieters K.

PLoS One. 2016 Apr 7;11(4):e0152315. doi: 10.1371/journal.pone.0152315. eCollection 2016.

10.

Quality of life in treatment of AK: Treatment burden of ingenol mebutate gel is small and short lasting.

Hanke WC, Norlin JM, Mark Knudsen K, Larsson T, Stone S.

J Dermatolog Treat. 2016 Oct;27(5):450-5. doi: 10.3109/09546634.2016.1160024. Epub 2016 Apr 7.

PMID:
27052110
11.

Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States.

Asche CV, Zografos P, Norlin JM, Urbanek B, Mamay C, Makin C, Erntoft S, Chen CC, Hines DM, Mark Siegel D.

Value Health. 2016 Mar-Apr;19(2):239-48. doi: 10.1016/j.jval.2015.11.014. Epub 2016 Jan 13.

12.

Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.

Calara PS, Norlin JM, Althin R, Carlsson KS, Schmitt-Egenolf M.

BioDrugs. 2016 Apr;30(2):145-51. doi: 10.1007/s40259-016-0163-8.

PMID:
26883786
13.

Register-Based Evaluation of Relative Effectiveness of New Therapies: Biologics Versus Conventional Agents in Treatment of Psoriasis in Sweden.

Norlin JM, Carlsson KS, Persson U, Schmitt-Egenolf M.

BioDrugs. 2015 Dec;29(6):389-98. doi: 10.1007/s40259-015-0151-4.

PMID:
26670179
14.

Health related quality of life in patients with actinic keratosis--an observational study of patients treated in dermatology specialist care in Denmark.

Tennvall GR, Norlin JM, Malmberg I, Erlendsson AM, Hædersdal M.

Health Qual Life Outcomes. 2015 Jul 29;13:111. doi: 10.1186/s12955-015-0295-4.

15.

Health Related Quality of Life in Patients With Actinic Keratosis - Results From Patients Treated in Dermatology Specialist Care In Denmark.

Ragnarson Tennvall G, Norlin JM, Malmberg I, Erlendsson A, Hædersdal M.

Value Health. 2014 Nov;17(7):A611. doi: 10.1016/j.jval.2014.08.2139. Epub 2014 Oct 26. No abstract available.

16.

[Register studies measure the effectiveness of drugs in clinical practice. The example PsoReg - redistribution of systemic treatment can increase the efficiency].

Norlin J, Schmitt-Egenolf M, Carlsson KS, Persson U.

Lakartidningen. 2014 Jun 11-17;111(24):1061-3. Swedish. No abstract available.

17.

Resource use in patients with psoriasis after the introduction of biologics in Sweden.

Norlin JM, Steen Carlsson K, Persson U, Schmitt-Egenolf M.

Acta Derm Venereol. 2015 Feb;95(2):156-61. doi: 10.2340/00015555-1895.

18.

A meta-analysis of expression signatures in glomerular disease.

Tryggvason SH, Guo J, Nukui M, Norlin J, Haraldsson B, Jörnvall H, Tryggvason K, He L.

Kidney Int. 2013 Sep;84(3):591-9. doi: 10.1038/ki.2013.169. Epub 2013 Jun 19.

19.

Switch to biological agent in psoriasis significantly improved clinical and patient-reported outcomes in real-world practice.

Norlin JM, Steen Carlsson K, Persson U, Schmitt-Egenolf M.

Dermatology. 2012;225(4):326-32. doi: 10.1159/000345715. Epub 2013 Jan 16.

20.

Prehospital chemical restraint of a noncommunicative autistic minor by law enforcement.

Ho JD, Nystrom PC, Calvo DV, Berris MS, Norlin JF, Clinton JE.

Prehosp Emerg Care. 2012 Jul-Sep;16(3):407-11. doi: 10.3109/10903127.2011.640767. Epub 2012 Jan 11.

PMID:
22235798
21.

Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.

Norlin JM, Steen Carlsson K, Persson U, Schmitt-Egenolf M.

Br J Dermatol. 2012 Apr;166(4):797-802. doi: 10.1111/j.1365-2133.2011.10778.x. Epub 2012 Mar 12.

PMID:
22182212
22.

Glcci1 deficiency leads to proteinuria.

Nishibori Y, Katayama K, Parikka M, Oddsson A, Nukui M, Hultenby K, Wernerson A, He B, Ebarasi L, Raschperger E, Norlin J, Uhlén M, Patrakka J, Betsholtz C, Tryggvason K.

J Am Soc Nephrol. 2011 Nov;22(11):2037-46. doi: 10.1681/ASN.2010111147. Epub 2011 Sep 23.

23.

Pericytes regulate the blood-brain barrier.

Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, Johansson BR, Betsholtz C.

Nature. 2010 Nov 25;468(7323):557-61. doi: 10.1038/nature09522. Epub 2010 Oct 13.

PMID:
20944627
24.

A cost-effectiveness analysis of diagnostic algorithms of deep vein thrombosis at the emergency department.

Norlin JM, Elf JL, Svensson PJ, Carlsson KS.

Thromb Res. 2010 Sep;126(3):195-9. doi: 10.1016/j.thromres.2010.05.013. Epub 2010 Jun 30.

PMID:
20580416
25.

Glomerular transcriptome changes associated with lipopolysaccharide-induced proteinuria.

Sun Y, He L, Takemoto M, Patrakka J, Pikkarainen T, Genové G, Norlin J, Truvé K, Tryggvason K, Betsholtz C.

Am J Nephrol. 2009;29(6):558-70. doi: 10.1159/000191469. Epub 2009 Jan 9.

PMID:
19136817
26.

The glomerular transcriptome and a predicted protein-protein interaction network.

He L, Sun Y, Takemoto M, Norlin J, Tryggvason K, Samuelsson T, Betsholtz C.

J Am Soc Nephrol. 2008 Feb;19(2):260-8. Epub 2007 Nov 21.

27.

The glomerular transcriptome and proteome.

Betsholtz C, He L, Takemoto M, Norlin J, Sun Y, Patrakka J, Tryggvason K.

Nephron Exp Nephrol. 2007;106(2):e32-6. Epub 2007 Jun 6. Review.

PMID:
17570937
28.

Glomerulus-specific mRNA transcripts and proteins identified through kidney expressed sequence tag database analysis.

He L, Sun Y, Patrakka J, Mostad P, Norlin J, Xiao Z, Andrae J, Tryggvason K, Samuelsson T, Betsholtz C, Takemoto M.

Kidney Int. 2007 May;71(9):889-900. Epub 2007 Feb 28.

29.

Platelet-derived growth factor B retention is essential for development of normal structure and function of conduit vessels and capillaries.

Nyström HC, Lindblom P, Wickman A, Andersson I, Norlin J, Fäldt J, Lindahl P, Skøtt O, Bjarnegård M, Fitzgerald SM, Caidahl K, Gan LM, Betsholtz C, Bergström G.

Cardiovasc Res. 2006 Aug 1;71(3):557-65. Epub 2006 May 25.

PMID:
16831408
30.

Microarray analysis of blood microvessels from PDGF-B and PDGF-Rbeta mutant mice identifies novel markers for brain pericytes.

Bondjers C, He L, Takemoto M, Norlin J, Asker N, Hellström M, Lindahl P, Betsholtz C.

FASEB J. 2006 Aug;20(10):1703-5. Epub 2006 Jun 28.

PMID:
16807374
31.

Platelet-derived growth factor receptor-beta promotes early endothelial cell differentiation.

Rolny C, Nilsson I, Magnusson P, Armulik A, Jakobsson L, Wentzel P, Lindblom P, Norlin J, Betsholtz C, Heuchel R, Welsh M, Claesson-Welsh L.

Blood. 2006 Sep 15;108(6):1877-86. Epub 2006 May 11.

32.

Large-scale identification of genes implicated in kidney glomerulus development and function.

Takemoto M, He L, Norlin J, Patrakka J, Xiao Z, Petrova T, Bondjers C, Asp J, Wallgard E, Sun Y, Samuelsson T, Mostad P, Lundin S, Miura N, Sado Y, Alitalo K, Quaggin SE, Tryggvason K, Betsholtz C.

EMBO J. 2006 Mar 8;25(5):1160-74. Epub 2006 Feb 23.

33.

Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities.

Bjarnegård M, Enge M, Norlin J, Gustafsdottir S, Fredriksson S, Abramsson A, Takemoto M, Gustafsson E, Fässler R, Betsholtz C.

Development. 2004 Apr;131(8):1847-57.

34.

Social work administrators in part-time clinical practice: results of a national survey.

Chess WA, Norlin JM, Jayaratne S.

Adm Soc Work. 1984 Fall;8(3):29-40. No abstract available.

PMID:
10310793

Supplemental Content

Loading ...
Support Center